BioCentury
ARTICLE | Company News

GlaxoSmithKline, Medicines for Malaria Venture, University of California deal

October 15, 2001 7:00 AM UTC

The parties will develop malaria therapies. GSK will contribute certain patents covering the treatment and prevention of malaria by compounds that inhibit falcipain, a digestive enzyme used by the par...